Lonnel Coats

Lonnel Coats

Chief Executive Officer at LEXICON PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 30/03/2024

58 year
Health Technology
Consumer Services

Profile

Lonnel Coats founded Eisai Corp. of North America. Currently, Mr. Coats is President, Chief Executive Officer & Director at Lexicon Pharmaceuticals, Inc. Mr. Coats is also on the board of Blueprint Medicines Corp. In the past Mr. Coats occupied the position of Executive Vice President at Eisai Co., Ltd. President & Chief Executive Officer of Eisai, Inc. and President & Chief Operating Officer for Eisai Corp. of North America (both are subsidiaries of Eisai Co., Ltd.). Lonnel Coats received an undergraduate degree from Oakland University (Michigan).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/03/2024 1,098,068 ( 0.45% ) 3 M $ 30/03/2024
20/06/2023 11,012 ( 0.02% ) 1 M $ 30/03/2024
14/06/2023 0 ( -.--% ) - $ 30/03/2024

Lonnel Coats active positions

CompaniesPositionStart
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer 06/07/2014
BLUEPRINT MEDICINES CORPORATION Director/Board Member 03/02/2016
VERVE THERAPEUTICS, INC. Director/Board Member 07/08/2022
All active positions of Lonnel Coats

Former positions of Lonnel Coats

CompaniesPositionEnd
Chief Executive Officer 31/12/2013
Chief Executive Officer 31/12/2013
Director/Board Member 28/01/2008
EISAI CO., LTD. President 15/09/2010
See the detail of Lonnel Coats's experience

Training of Lonnel Coats

Oakland University (Michigan) Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lonnel Coats's experience

Connections

99

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
LEXICON PHARMACEUTICALS, INC.

Health Technology

EISAI CO., LTD.

Health Technology

BLUEPRINT MEDICINES CORPORATION

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Verve Therapeutics, Inc.

See company connections